Recent Articles By The Author
Are Fund Managers Better Than Their Funds?
For investors still cringing at their IRAs, 401(k)s or taxable mutual funds and exchange-traded funds, are you ready to take a chance on the companies that have brought you so many unhappy returns?
Can Regional Brokers Keep Outperforming?
The regionals may not have as much recognition as the mammoth securities firms, but they won't be receiving as many unwanted headlines either.
Wyeth Deal's Big, but Pfizer Still Needs a Blockbuster
If Pfizer's looking for the next Lipitor, it probably hasn't found it with the acquisition of Wyeth.
Cosmetic Surgery Stocks Keep Stiff Upper Lip
Allergan, Mentor and Medicis have struggled in the past year, but if the economy improves, share prices could, too.
For Abbott, Diversity Remains Paramount
When it comes to investing in big pharmaceutical stocks, it's hard to top this company, especially as its peers continue to suffer.